Regions Financial Corp Abb Vie Inc. Transaction History

Regions Financial Corp

  • $13.8 Billion
  • Q3 2024

A detailed history of Regions Financial Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Regions Financial Corp holds 412,529 shares of ABBV stock, worth $69.2 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
412,529
Previous 407,592 1.21%
Holding current value
$69.2 Million
Previous $69.9 Million 16.53%
% of portfolio
0.59%
Previous 0.53%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$163.84 - $199.33 $808,878 - $984,092
4,937 Added 1.21%
412,529 $81.5 Million
Q2 2024

Jul 31, 2024
BUY
$154.79 - $180.76 $31.2 Million - $36.5 Million
201,676 Added 97.94%
407,592 $69.9 Million
Q1 2024

Apr 23, 2024
BUY
$159.82 - $182.1 $1.18 Million - $1.34 Million
7,371 Added 3.71%
205,916 $37.5 Million
Q4 2023

Feb 06, 2024
SELL
$137.6 - $154.97 $916,553 - $1.03 Million
-6,661 Reduced 3.25%
198,545 $30.8 Million
Q3 2023

Nov 01, 2023
SELL
$133.59 - $154.65 $744,229 - $861,555
-5,571 Reduced 2.64%
205,206 $30.6 Million
Q2 2023

Aug 09, 2023
BUY
$132.51 - $164.9 $1.2 Million - $1.5 Million
9,070 Added 4.5%
210,777 $28.4 Million
Q1 2023

May 12, 2023
SELL
$144.61 - $166.54 $3.75 Million - $4.32 Million
-25,955 Reduced 11.4%
201,707 $32.1 Million
Q4 2022

Feb 03, 2023
SELL
$138.31 - $165.87 $1.33 Million - $1.6 Million
-9,627 Reduced 4.06%
227,662 $36.8 Million
Q3 2022

Nov 03, 2022
SELL
$134.21 - $153.93 $2.54 Million - $2.92 Million
-18,952 Reduced 7.4%
237,289 $31.8 Million
Q2 2022

Jul 25, 2022
SELL
$137.62 - $174.96 $3.43 Million - $4.37 Million
-24,951 Reduced 8.87%
256,241 $39.2 Million
Q1 2022

Apr 25, 2022
SELL
$131.98 - $163.75 $11.4 Million - $14.1 Million
-86,403 Reduced 23.5%
281,192 $45.6 Million
Q4 2021

Jan 31, 2022
SELL
$107.43 - $135.93 $29.4 Million - $37.2 Million
-273,864 Reduced 42.69%
367,595 $49.8 Million
Q3 2021

Nov 04, 2021
SELL
$106.4 - $120.78 $1.86 Million - $2.12 Million
-17,522 Reduced 2.66%
641,459 $69.2 Million
Q2 2021

Jul 27, 2021
SELL
$105.21 - $117.21 $598,434 - $666,690
-5,688 Reduced 0.86%
658,981 $74.2 Million
Q1 2021

Jun 02, 2021
BUY
$102.3 - $112.62 $599,375 - $659,840
5,859 Added 0.89%
664,669 $71.9 Million
Q4 2020

Feb 05, 2021
BUY
$80.49 - $108.67 $158,082 - $213,427
1,964 Added 0.3%
658,810 $70.6 Million
Q3 2020

Oct 15, 2020
BUY
$85.91 - $100.83 $1.05 Million - $1.23 Million
12,176 Added 1.89%
656,846 $57.5 Million
Q2 2020

Jul 27, 2020
BUY
$73.37 - $98.18 $2.51 Million - $3.36 Million
34,189 Added 5.6%
644,670 $63.3 Million
Q1 2020

Apr 29, 2020
BUY
$64.5 - $97.79 $26.1 Million - $39.5 Million
404,295 Added 196.08%
610,481 $46.5 Million
Q4 2019

Feb 03, 2020
SELL
$72.13 - $90.25 $11,829 - $14,801
-164 Reduced 0.08%
206,186 $18.3 Million
Q3 2019

Oct 24, 2019
SELL
$62.98 - $75.72 $1.11 Million - $1.34 Million
-17,693 Reduced 7.9%
206,350 $15.6 Million
Q2 2019

Jul 19, 2019
BUY
$65.7 - $83.98 $465,813 - $595,418
7,090 Added 3.27%
224,043 $16.3 Million
Q1 2019

Apr 19, 2019
SELL
$77.14 - $90.79 $1.84 Million - $2.17 Million
-23,853 Reduced 9.91%
216,953 $17.5 Million
Q4 2018

Jan 28, 2019
SELL
$77.85 - $96.01 $163,173 - $201,236
-2,096 Reduced 0.86%
240,806 $22.2 Million
Q3 2018

Oct 22, 2018
BUY
$88.91 - $98.84 $199,691 - $221,994
2,246 Added 0.93%
242,902 $23 Million
Q2 2018

Jul 26, 2018
BUY
$89.78 - $106.23 $162,771 - $192,594
1,813 Added 0.76%
240,656 $22.3 Million
Q1 2018

Apr 18, 2018
SELL
$92.01 - $123.21 $2.15 Million - $2.87 Million
-23,321 Reduced 8.9%
238,843 $22.6 Million
Q4 2017

Jan 18, 2018
SELL
$89.56 - $98.21 $478,698 - $524,932
-5,345 Reduced 2.0%
262,164 $25.4 Million
Q3 2017

Oct 23, 2017
BUY
$69.85 - $89.22 $18.7 Million - $23.9 Million
267,509
267,509 $23.8 Million

Others Institutions Holding ABBV

# of Institutions
3,846
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Regions Financial Corp Portfolio

Follow Regions Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Regions Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email